PLA2R1 and idiopathic membranous glomerulonephritis: In the extended Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy (GEMRITUX) study, investigators suggested that a baseline PLA2R-Ab level < 275 RU/mL was independently associated with complete or partial remission of proteinuria at 6 months [10].